Product Description: LRRK2-IN-13 (Compound 13) is an inhibitor of LRRK2 (IC50=0.57 nM). LRRK2-IN-13 has brain penetrating properties[1].
Formula: C19H19ClN8O2
References: [1]Jensen, T, et al. Preparation of substituted 2,4,12,13-tetrahydro-11H-5,7-(azenometheno)dipyrazolo[3,4-b:5',1'-g][1]oxa[4,6,8]triazacycloundecine derivatives as leucine-rich repeat kinase 2 (LRKK2) inhibitors. World Intellectual Property Organization, WO2024056775 A1 2024-03-21
CAS Number: 3032733-17-5
Molecular Weight: 426.86
Research Area: Neurological Disease
Solubility: 10 mM in DMSO
Target: LRRK2